Last edition
News about Global Pharma
The expanded collaboration will leverage Orbit Discovery’s proprietary screening platform to identify and optimize peptide candidates, combined with Evergreen Theragnostics’ expertise in radiopharmaceutical development and clinical translation.
Global Pharma | 04/12/2024 | By Aishwarya | 356
Martin Pharmaceuticals Gets Exclusive Rights from MTPC for Docarpamine
The Phase 2a open-label trial enrolled 16 patients with refractory ascites requiring regular large-volume paracentesis (LVP).
Global Pharma | 04/12/2024 | By Aishwarya | 556
Ampersand Capital Partners Launches Newly Branded Business Gannet BioChem
The new Ampersand portfolio company will be branded Gannet BioChem and will continue to operate out of its state-of-the-art facility in Huntsville, Alabama.
Global Pharma | 03/12/2024 | By Aishwarya | 920
CBC Group Acquires UCB's Mature Product Portfolio in China
The acquisition marks another successful transaction under CBC's buyout strategy of acquiring key assets from global pharmaceutical companies and a significant step in establishing a market-leading neurology company in China while expanding CBC's portfolio within the region's dynamic pharmaceutical market.
Global Pharma | 03/12/2024 | By Aishwarya | 872
Roche Announces Acquisition of Poseida Therapeutics
The proposed acquisition will establish a new core capability for Roche in allogeneic cell therapy, with lead opportunities focused on CAR-T programs covered by the existing strategic collaboration between Poseida and Roche in hematologic malignancies.
Global Pharma | 03/12/2024 | By Aishwarya | 462
Brenntag, K+S to Expand its Business in High-Purity Salts for Pharma Applications
Brenntag will now distribute three of their salts in the pharmaceutical market: APISAL Sodium Chloride GMP grade (in pharmacopoeia quality, API), Potassium Chloride 99.9 percent KCl Ph. Eur., USP (API) and HD-NaCl (excipient grade).
Global Pharma | 03/12/2024 | By Aishwarya | 363
Allink Biotherapeutics Secures USD 42 Million Series A Financing Round
The financing round was led by Lanchi Ventures, a preeminent global early-stage technology investor known for backing breakthrough innovations, with participation from an elite syndicate of new investors.
Global Pharma | 02/12/2024 | By Aishwarya | 326
ASPA Promotes Members' Anti-Counterfeiting Solutions Globally
In his address, Puneet highlighted ASPA's growing global presence and its strategic efforts to fight counterfeiting by promoting the innovative anti-counterfeiting solutions offered by its members internationally.
Global Pharma | 02/12/2024 | By Aishwarya | 629
MGI Tech Partners with Universidad de San Martin de Porres to Boost Human Genetics Research
This advancement will enable the identification of genetic risk factors in the population for the development of future public health treatments.
Global Pharma | 02/12/2024 | By Aishwarya | 337
OPPI Annual Summit Presents Roadmap on Becoming Pharma Powerhouse Globally
Centered around the theme Viksit Bharat @2047 — India's Path from the 'Pharmacy of the World' to the 'Pharma Powerhouse to the World', the summit set forth the vision for India's healthcare evolution.
Global Pharma | 29/11/2024 | By Aishwarya | 652
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy